{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:36:34Z","timestamp":1793154994944,"version":"4.5.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Overdiagnosis is the concept that some cancers detected at screening would never have become clinically apparent during a woman\u2019s lifetime in the absence of screening. This could occur if a woman dies of a cause other than breast cancer in the interval between mammographic detection and clinical detection (obligate overdiagnosis) or if a mammographically detected breast cancer fails to progress to clinical presentation. Overdiagnosis cannot be measured directly. Indirect methods of estimating overdiagnosis include use of data from randomized controlled trials (RCTs) designed to evaluate breast cancer mortality, population-based screening studies, or modeling. In each case, estimates of overdiagnosis must consider lead time, breast cancer incidence trends in the absence of screening, and accurate and predictable rates of tumor progression. Failure to do so has led to widely varying estimates of overdiagnosis. The U.S. Preventive Services Task Force (USPSTF) considers overdiagnosis a major harm of mammography screening. Their 2024 report estimated overdiagnosis using summary evaluations of 3 RCTs that did not provide screening to their control groups at the end of the screening period, along with Cancer Intervention and Surveillance Network modeling. However, there are major flaws in their evidence sources and modeling estimates, limiting the USPSTF assessment. The most plausible estimates remain those based on observational studies that suggest overdiagnosis in breast cancer screening is 10% or less and can be attributed primarily to obligate overdiagnosis and nonprogressive ductal carcinoma in situ.<\/jats:p>","DOI":"10.1093\/jbi\/wbae028","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T17:27:13Z","timestamp":1718213233000},"page":"338-346","source":"Crossref","is-referenced-by-count":6,"title":["USPSTF Recommendations and Overdiagnosis"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9971-2651","authenticated-orcid":false,"given":"R Edward","family":"Hendrick","sequence":"first","affiliation":[{"name":"Department of Radiology, University of Colorado Anschutz School of Medicine , Aurora, CO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L","family":"Monticciolo","sequence":"additional","affiliation":[{"name":"Dartmouth Geisel School of Medicine , Lebanon, NH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"issue":"3","key":"2024073019320582200_CIT0001","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1148\/radiol.2021203935","article-title":"Beneficial effect of consecutive screening mammography examinations on mortality from breast cancer: a prospective study","volume":"299","author":"Duffy","year":"2021","journal-title":"Radiology"},{"issue":"11","key":"2024073019320582200_CIT0002","doi-asserted-by":"crossref","first-page":"dju261","DOI":"10.1093\/jnci\/dju261","article-title":"Pan-Canadian study of mammography screening and mortality from breast cancer","volume":"106","author":"Coldman","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"2024073019320582200_CIT0003","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/cncr.32859","article-title":"Mammography screening reduces rates of advanced and fatal breast cancers: results in 549,091 women","volume":"126","author":"Duffy","year":"2020","journal-title":"Cancer"},{"issue":"Suppl 1","key":"2024073019320582200_CIT0004","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1258\/jms.2012.012078","article-title":"The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies","volume":"19","author":"Broeders","year":"2012","journal-title":"J Med Screen"},{"key":"2024073019320582200_CIT0005","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1158\/1055-9965.EPI-12-0468","article-title":"Mammographic screening and breast cancer mortality: a case\u2013control study and meta-analysis","volume":"21","author":"Nickson","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"2024073019320582200_CIT0006","doi-asserted-by":"crossref","first-page":"e232658","DOI":"10.1148\/radiol.232658","article-title":"Outcomes of breast cancer screening strategies based on Cancer Intervention and Surveillance Modeling Network estimates","volume":"310","author":"Monticciolo","year":"2024","journal-title":"Radiology"},{"issue":"4","key":"2024073019320582200_CIT0007","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cncr.31840","article-title":"The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening","volume":"125","author":"Tab\u00e1r","year":"2019","journal-title":"Cancer"},{"key":"2024073019320582200_CIT0008","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejca.2016.12.030","article-title":"Advanced breast cancer rates in the epoch of service screening: the 400,000 women cohort study from Italy","volume":"75","author":"Puliti","year":"2017","journal-title":"Eur J Cancer"},{"issue":"3","key":"2024073019320582200_CIT0009","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1148\/radiol.11111734","article-title":"Impact of mammography detection on the course of breast cancer in women aged 40-49 years","volume":"262","author":"Malmgren","year":"2012","journal-title":"Radiology"},{"issue":"3","key":"2024073019320582200_CIT0010","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1148\/radiol.14140209","article-title":"Improved prognosis of women aged 75 and older with mammography-detected breast cancer","volume":"273","author":"Malmgren","year":"2014","journal-title":"Radiology"},{"issue":"1","key":"2024073019320582200_CIT0011","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2214\/ajr.184.1.01840324","article-title":"Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy","volume":"184","author":"Barth","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"2024073019320582200_CIT0012","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/ijc.22545","article-title":"A retrospective study of the effect of participation in screening mammography on the use of chemotherapy and breast conserving surgery","volume":"120","author":"Coldman","year":"2007","journal-title":"Int J Cancer"},{"issue":"4","key":"2024073019320582200_CIT0013","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1075-122X.2004.21461.x","article-title":"Mammographic screening and disease presentation of breast cancer patients who die of disease","volume":"10","author":"Spencer","year":"2004","journal-title":"Breast J"},{"issue":"9","key":"2024073019320582200_CIT0014","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/sj.bjc.6603405","article-title":"Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997-2001)","volume":"95","author":"Zorzi","year":"2006","journal-title":"Br J Cancer"},{"issue":"8","key":"2024073019320582200_CIT0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-158-8-201304160-00005","article-title":"Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force","volume":"158","author":"Nelson","year":"2013","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"2024073019320582200_CIT0016","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1258\/jms.2012.012082","article-title":"Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review","volume":"19","author":"Puliti","year":"2012","journal-title":"J Med Screen"},{"issue":"2","key":"2024073019320582200_CIT0017","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1148\/radiol.2017171622","article-title":"Obligate overdiagnosis due to mammographic screening: a direct estimate for U.S. women","volume":"287","author":"Hendrick","year":"2018","journal-title":"Radiology"},{"issue":"4","key":"2024073019320582200_CIT0018","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7326\/M21-3577","article-title":"Estimation of breast cancer overdiagnosis in a U.S. breast screening cohort","volume":"175","author":"Ryser","year":"2022","journal-title":"Ann Intern Med"},{"issue":"11","key":"2024073019320582200_CIT0019","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/bjc.2013.177","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"108","author":"Marmot","year":"2013","journal-title":"Br J Cancer"},{"issue":"Suppl 1","key":"2024073019320582200_CIT0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1258\/jms.2012.012077","article-title":"EUROSCREEN Working Group. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet","volume":"19","author":"Paci","year":"2012","journal-title":"J Med Screen"},{"key":"2024073019320582200_CIT0021","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"2024073019320582200_CIT0022","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/bjc.2013.427","article-title":"Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis","volume":"109","author":"Zahl","year":"2013","journal-title":"Br J Cancer"},{"key":"2024073019320582200_CIT0023","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/bmj.38044.666157.63","article-title":"Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study","volume":"328","author":"Zahl","year":"2004","journal-title":"BMJ"},{"key":"2024073019320582200_CIT0024","doi-asserted-by":"crossref","first-page":"b2587","DOI":"10.1136\/bmj.b2587","article-title":"Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends","volume":"339","author":"J\u00f8rgensen","year":"2009","journal-title":"BMJ"},{"issue":"10","key":"2024073019320582200_CIT0025","doi-asserted-by":"crossref","first-page":"716","DOI":"10.7326\/0003-4819-151-10-200911170-00008","article-title":"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement","volume":"151","author":"U.S. Preventive Services Task Force","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"2024073019320582200_CIT0026","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"issue":"4","key":"2024073019320582200_CIT0027","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/M15-1536","article-title":"Collaborative modeling of the benefits and harms associated with different U.S. breast cancer screening strategies","volume":"164","author":"Mandelblatt","year":"2016","journal-title":"Ann Intern Med"},{"key":"2024073019320582200_CIT0028","author":"US Preventive Services Task Force. Screening for breast cancer"},{"key":"2024073019320582200_CIT0029","doi-asserted-by":"crossref","volume-title":"Screening for breast cancer: evidence report and systematic review for the US preventive services task force.","author":"Henderson","DOI":"10.1001\/jama.2023.25844"},{"key":"2024073019320582200_CIT0030","doi-asserted-by":"crossref","volume-title":"Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US preventive services task force.","author":"Trentham-Dietz","DOI":"10.1001\/jama.2023.24766"},{"issue":"5","key":"2024073019320582200_CIT0031","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-137-5_Part_1-200209030-00005","article-title":"The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years","volume":"137","author":"Miller","year":"2002","journal-title":"Ann Intern Med"},{"issue":"18","key":"2024073019320582200_CIT0032","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/jnci\/92.18.1490","article-title":"Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years","volume":"92","author":"Miller","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"7543","key":"2024073019320582200_CIT0033","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/bmj.38764.572569.7C","article-title":"Rate of overdiagnosis of breast cancer 15 years after end of Malm\u00f6 mammographic screening trial: follow-up study","volume":"332","author":"Zackrisson","year":"2006","journal-title":"BMJ"},{"issue":"1","key":"2024073019320582200_CIT0034","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/09691413211059461","article-title":"The randomized trial of mammography screening that was not \u2013 a cautionary tale","volume":"29","author":"Yaffe","year":"2022","journal-title":"J Med Screen"},{"key":"2024073019320582200_CIT0035","first-page":"108","article-title":"The fundamental flaws of the CNBSS trials: a scientific review. J Breast Imag","author":"Yaffe","year":"2022"},{"key":"2024073019320582200_CIT0036","first-page":"135","article-title":"Errors in conduct of the CNBSS trials of breast cancer screening observed by research personnel. J Breast Imag","author":"Seely","year":"2022"},{"issue":"2","key":"2024073019320582200_CIT0037","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/0969141320986186","article-title":"Major failings of trial procedures and quality of screening fatally compromise the results of the Canadian National Breast Screening Studies","volume":"28","author":"Kopans","year":"2021","journal-title":"J Med Screen"},{"key":"2024073019320582200_CIT0038","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1148\/radiology.189.3.8234686","article-title":"A critical appraisal of the Canadian National Breast Cancer Screening Study","volume":"189","author":"Boyd","year":"1993","journal-title":"Radiology"},{"key":"2024073019320582200_CIT0039","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/1097-0142(19950215)75:4<997::AID-CNCR2820750415>3.0.CO;2-M","article-title":"The excess of patients with advanced breast cancers in young women screened with mammography in the Canadian National Breast Screening Study","volume":"75","author":"Tarone","year":"1995","journal-title":"Cancer"},{"key":"2024073019320582200_CIT0040","volume-title":"Screening for breast cancer: a systematic review to update the 2009 U.S. Preventive Services Task Force Recommendation. Evidence Synthesis No. 124. AHRQ Publication No. 14-05201-EF-1","author":"Nelson","year":"2016"},{"issue":"9","key":"2024073019320582200_CIT0041","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacr.2021.04.021","article-title":"Breast cancer screening recommendations inclusive of all women at average risk: update from the ACR and Society of Breast Imaging","volume":"18","author":"Monticciolo","year":"2021","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"2024073019320582200_CIT0042","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2023.0031","article-title":"NCCN guidelines insights: breast cancer, version 4.2023","volume":"21","author":"Gradishar","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"2024073019320582200_CIT0043","volume-title":"SEER*Stat Database: Incidence - SEER Research Data, 17 Registries, Nov 2022 Sub (2000-2020) - Linked to County Attributes - Time Dependent (1990-2021) Income\/Rurality, 1969-2021 Counties","author":"Surveillance, Epidemiology, and End Results (SEER) Program","year":"2023"},{"key":"2024073019320582200_CIT0044"},{"issue":"7","key":"2024073019320582200_CIT0045","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jacr.2017.01.038","article-title":"Persistent untreated screening-detected breast cancer: an argument against delaying screening or increasing the interval between screenings","volume":"14","author":"Arleo","year":"2017","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"2024073019320582200_CIT0046","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2214\/AJR.20.23467","article-title":"Annual screening mammography associated with lower stage breast cancer compared with biennial screening","volume":"217","author":"Moorman","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"2024073019320582200_CIT0047","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fpubh.2014.00087","article-title":"Delay in breast cancer: implications for stage at diagnosis and survival","volume":"2","author":"Caplan","year":"2014","journal-title":"Front Public Health"},{"key":"2024073019320582200_CIT0048","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/02841869009090048","article-title":"The spontaneous regression of cancer: a review of cases from 1900 to 1987","volume":"29","author":"Challis","year":"1990","journal-title":"Acta Oncologica"},{"issue":"1","key":"2024073019320582200_CIT0049","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jso.2930190107","article-title":"Spontaneous regression of breast carcinoma: follow-up report and literature review","volume":"19","author":"Ross","year":"1982","journal-title":"J Surg Oncol"},{"issue":"3","key":"2024073019320582200_CIT0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000112228","article-title":"Spontaneous regression of a breast carcinoma: a case report","volume":"65","author":"Dussan","year":"2008","journal-title":"Gynecol Obstet Invest"},{"issue":"1_suppl","key":"2024073019320582200_CIT0051","doi-asserted-by":"crossref","first-page":"126S","DOI":"10.1177\/0272989X17729358","article-title":"Modeling ductal carcinoma in situ (DCIS): an overview of CISNET model approaches","volume":"38","author":"van Ravesteyn","year":"2018","journal-title":"Med Decis Making"},{"issue":"1_suppl","key":"2024073019320582200_CIT0052","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1177\/0272989X17737507","article-title":"Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) breast cancer models","volume":"38","author":"Alagoz","year":"2018","journal-title":"Med Decis Making"},{"issue":"1_suppl","key":"2024073019320582200_CIT0053","doi-asserted-by":"crossref","first-page":"9S","DOI":"10.1177\/0272989X17700624","article-title":"Common model inputs used in CISNET collaborative breast cancer modeling","volume":"38","author":"Mandelblatt","year":"2018","journal-title":"Med Decis Making"},{"issue":"6","key":"2024073019320582200_CIT0054","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1158\/1055-9965.EPI-14-1286","article-title":"The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model","volume":"24","author":"Gangnon","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1_suppl","key":"2024073019320582200_CIT0055","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1177\/0272989X17711927","article-title":"The University of Wisconsin breast cancer epidemiology simulation model: an update","volume":"38","author":"Alagoz","year":"2018","journal-title":"Med Decis Making"},{"issue":"1_suppl","key":"2024073019320582200_CIT0056","doi-asserted-by":"crossref","first-page":"66S","DOI":"10.1177\/0272989X17698685","article-title":"Structure, function, and applications of the Georgetown-Einstein (GE) breast cancer simulation model","volume":"38","author":"Schechter","year":"2018","journal-title":"Med Decis Making"},{"issue":"1_suppl","key":"2024073019320582200_CIT0057","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1177\/0272989X17714473","article-title":"A Bayesian simulation model for breast cancer screening, incidence, treatment, and mortality","volume":"38","author":"Huang","year":"2018","journal-title":"Med Decis Making"},{"issue":"1_suppl","key":"2024073019320582200_CIT0058","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1177\/0272989X17741634","article-title":"The Dana-Farber CISNET model for breast cancer screening strategies: an update","volume":"38","author":"Lee","year":"2018","journal-title":"Med Decis Making"},{"key":"2024073019320582200_CIT0059","volume-title":"Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence - SEER Research Data, 8 Registries, Nov 2022 Sub (1975-2020) - Linked to County Attributes - Time Dependent (1990-2021) Income\/Rurality, 1969-2021 Counties","year":"2023"},{"issue":"1 Suppl","key":"2024073019320582200_CIT0060","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cncr.2820741304","article-title":"Changing trends: an overview of breast cancer incidence and mortality","volume":"74","author":"Garfinkel","year":"1994","journal-title":"Cancer"},{"issue":"17","key":"2024073019320582200_CIT0061","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/cncr.28784","article-title":"Reduction in late-stage breast cancer incidence in the mammography era: implications for overdiagnosis of invasive cancer","volume":"120","author":"Helvie","year":"2014","journal-title":"Cancer"},{"key":"2024073019320582200_CIT0062","author":"Connecticut State Department of Health"},{"key":"2024073019320582200_CIT0063","volume-title":"SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2017 Sub (1973-2015) &lt;Katrina\/Rita Population Adjustment&gt; - Linked to County Attributes - Total U.S., 1969-2016 Counties","author":"Surveillance, Epidemiology, and End Results (SEER) Program","year":"2018"},{"key":"2024073019320582200_CIT0064","volume-title":"Joinpoint. Version 5.0.2.","year":"2023"}],"container-title":["Journal of Breast Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbi\/article-pdf\/6\/4\/338\/58695038\/wbae028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbi\/article-pdf\/6\/4\/338\/58695038\/wbae028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T01:14:10Z","timestamp":1722388450000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbi\/article\/6\/4\/338\/7691827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,6,12]]},"published-print":{"date-parts":[[2024,7,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jbi\/wbae028","relation":{},"ISSN":["2631-6110","2631-6129"],"issn-type":[{"value":"2631-6110","type":"print"},{"value":"2631-6129","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,6,12]]}}}